VLPs are well suited as vaccines for enveloped and non-enveloped viral targets (e.g. RSV, HCV, Dengue, Influenza, HPV etc.) triggering innate and adaptive immune response.
Unique selling points of Redbiotec's reVLPs as vaccines:
- Safe, non-replicative virus elements
- Strong protective immonogenicity thanks to polyprotein surface and capsid (real "virus mimick")
- Option: Multiple serotypes/ strains ("chimeric VLPs")
- Option: Boosting factors (such as T-cell epitopes, CpG)